FDA Inspection 1118383 — Marina Nikanorova, M.D.
The FDA completed an inspection of Marina Nikanorova, M.D. on January 24, 2020 in Dianalund. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 24, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dianalund (Denmark)
Additional Details
Clinical Investigator (CI)